| 000 | 01890 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250512031413.0 | ||
| 264 | 0 | _c19860612 | |
| 008 | 198606s 0 0 eng d | ||
| 022 | _a0028-4793 | ||
| 024 | 7 |
_a10.1056/NEJM198605223142105 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMascola, L | |
| 245 | 0 | 0 |
_aScreening to reduce transmission of sexually transmitted diseases in semen used for artificial insemination. _h[electronic resource] |
| 260 |
_bThe New England journal of medicine _cMay 1986 |
||
| 300 |
_a1354-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aChlamydia trachomatis _xisolation & purification |
| 650 | 0 | 4 |
_aCytomegalovirus _xisolation & purification |
| 650 | 0 | 4 |
_aDeltaretrovirus _xisolation & purification |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatitis B virus _xisolation & purification |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 |
_aInsemination, Artificial _xadverse effects |
| 650 | 0 | 4 |
_aInsemination, Artificial, Heterologous _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMycoplasma _xisolation & purification |
| 650 | 0 | 4 |
_aNeisseria gonorrhoeae _xisolation & purification |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aSemen _xmicrobiology |
| 650 | 0 | 4 |
_aSexually Transmitted Diseases _xprevention & control |
| 650 | 0 | 4 |
_aSimplexvirus _xisolation & purification |
| 650 | 0 | 4 |
_aStreptococcus _xisolation & purification |
| 650 | 0 | 4 | _aTissue Donors |
| 650 | 0 | 4 |
_aTreponema pallidum _xisolation & purification |
| 650 | 0 | 4 |
_aTrichomonas vaginalis _xisolation & purification |
| 650 | 0 | 4 |
_aUreaplasma _xisolation & purification |
| 700 | 1 | _aGuinan, M E | |
| 773 | 0 |
_tThe New England journal of medicine _gvol. 314 _gno. 21 _gp. 1354-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJM198605223142105 _zAvailable from publisher's website |
| 999 |
_c3015926 _d3015926 |
||